Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03536546 · ClinicalTrials.gov registry record · NA

Improving Outcomes for Emergency Department Patients With Alcohol Problems

A NA study, sponsored by VA Office of Research and Development.

Completed
Registry status
NA
Development phase
206
Enrollment target

NCT03536546: Completed NA study, sponsored by VA Office of Research and Development.

NCT03536546 is a NA study that has completed, run by VA Office of Research and Development. The registered enrollment target is 206 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (85% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT03536546, a NA study, has completed, sponsored by VA Office of Research and Development.

COMPLETED
Registry status
NA
Development phase
206 participants
Enrollment target

Study Summary

The investigators will conduct a study to examine the impact of an alcohol peer-mentor intervention starting in the emergency department (ED) combined with 6 peer booster sessions to reduce hazardous drinking and facilitate primary/specialty care use compared to enhanced usual care. Approximately 450 Veterans with hazardous drinking behaviors will be randomized to one of these two conditions. Follow-up assessments will occur at 3-, 6-, and 12-month post-randomization.

Primary Outcome

Alcohol consumption is measured by Timeline Follow-Back (TLFB). The investigators will administer a 30-day TLFB for finer grained data on participant's self-reported drinking behaviors. The investigators will collect participant self-report data on number of drinks per day on days of drinking.

Interventions

  • BEHAVIORAL Brief Advice
  • BEHAVIORAL Alcohol Peer Mentor Intervention

Trial Details

FieldValue
Enrollment Target 206 participants
Start Date 2019-06-10
Est. Completion 2023-06-30
Phase NA
VA Office of Research and Development

1,668 total trials

What the finished NCT03536546 record still lists

NCT03536546 is an interventional study that assigns participants to a tested intervention. The registered 206 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (85% lower).

The record links to 0 conditions, and to 2 interventions - of which Brief Advice is the first listed.

NCT03536546 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03536546 about?

NCT03536546 is a clinical study titled "Improving Outcomes for Emergency Department Patients With Alcohol Problems". The investigators will conduct a study to examine the impact of an alcohol peer-mentor intervention starting in the emergency department (ED) combined with 6 peer booster sessions to reduce hazardous drinking and facilitate primary/specialty care use compared to enhanced usual care. Approximately 45...

What is the current status of trial NCT03536546?

This trial is currently completed. It is a NA study. The enrollment target is 206 participants. The study started on 2019-06-10. Estimated completion is 2023-06-30.

What interventions are being tested in trial NCT03536546?

The interventions under investigation include: Brief Advice (BEHAVIORAL), Alcohol Peer Mentor Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT03536546?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03536546's enrollment target sits among peer trials

206 499th of 2000 higher than 1,502 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03373968 · 206 participants · Phase 2

    Givinostat in Duchenne's Muscular Dystrophy Long-term Safety and Tolerability Study

  • NCT03550391 · 206 participants · Phase 3

    Stereotactic Radiosurgery Compared With Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) Plus Memantine for 5 or More Brain Metastases

  • NCT04757116 · 206 participants · NA

    Post-Market Study to Assess iTind Safety in Comparison to UroLift

  • NCT05675865 · 206 participants · NA

    Cryoablation for Monomorphic Ventricular Tachycardia

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03536546, the US trial registry maintained by the National Library of Medicine. NCT03536546 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.